Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial
Open Access
- 15 January 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (2), 284-288
- https://doi.org/10.1086/379825
Abstract
As part of the Monoclonal Anti-TNF: A Randomized Controlled Sepsis (MONARCS) trial, which enrolled patients with suspected sepsis, we sought to deterKeywords
This publication has 15 references indexed in Scilit:
- Impact of Infectious Diseases Specialists and Microbiological Data on the Appropriateness of Antimicrobial Therapy for BacteremiaClinical Infectious Diseases, 1999
- The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in AdultsClinical Infectious Diseases, 1997
- Bacteraemia in a community and a university hospitalJournal of Antimicrobial Chemotherapy, 1995
- Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe SepsisJAMA, 1995
- Long-term survival following bacteremia or fungemiaPublished by American Medical Association (AMA) ,1995
- Excess Mortality in Critically III Patients with Nosocomial Bloodstream InfectionsChest, 1991
- A Three-Year Study of Positive Blood Cultures, with Emphasis on PrognosisClinical Infectious Diseases, 1990
- Sepsis syndromeCritical Care Medicine, 1989
- Bloodstream infections in the elderlyAmerican Journal Of Medicine, 1989
- Bacteremia at Boston City Hospital: Occurrence and Mortality during 12 Selected Years (1935-1972), with Special Reference to Hospital-Acquired CasesThe Journal of Infectious Diseases, 1975